ISRCTN ISRCTN72673620
DOI https://doi.org/10.1186/ISRCTN72673620
Secondary identifying numbers N/A
Submission date
18/04/2006
Registration date
05/05/2006
Last edited
11/02/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Respiratory
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data

Plain English Summary

Not provided at time of registration

Contact information

Prof Adnan Custovic
Scientific

North West Lung Research Centre
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
United Kingdom

Phone +44 (0)161 291 2494
Email adnan.custovic@manchester.ac.uk

Study information

Study designProspective observational birth cohort study
Primary study designObservational
Secondary study designCohort study
Study setting(s)Not specified
Study typeOther
Participant information sheet Not available in web format, please use the contact details below to request a patient information sheet
Scientific titleManchester Asthma and Allergy Study
Study acronymMAAS
Study hypothesisBirth cohort study investigating the development of asthma and allergic disease
Ethics approval(s)1. Age 0 - 5 years follow up, ERP/94/032, approval received on 24/03/1994
2. Age 5 - 8 years follow up, SOU/00/258 and SOU/00/259, approval received on 20/12/2000
3. Age 8 - 11 years follow up, 03/SM/400, approval received on 05/12/2003
ConditionAsthma and allergy
InterventionThis is a prospective, observational birth cohort study, which includes investigating environmental exposures, immune responses, behaviour or family functioning, genetic epidemiology, pulmonary physiology and clinical outcomes
Intervention typeOther
Primary outcome measure1. Asthma at age 5, 8, 11 and 14 years
2. Sensitisation at age 1, 3, 5, 8, 11 and 14 years
3. Allergies (e.g. hay fever) at age 5, 8, 11 and 14 years
Secondary outcome measures1. Wheeze and eczema at age 1, 3, 5, 8, 11 and 14 years
2. Healthcare utilisation by age 8 - 11 years
Overall study start date01/09/1995
Overall study end date01/06/2019

Eligibility

Participant type(s)Patient
Age groupChild
SexBoth
Target number of participants1250
Participant inclusion criteriaChildren born at Wythenshawe Hospital, Manchester and Stepping Hill Hospital, Stockport between January 1996 and April 1998
Participant exclusion criteriaPremature birth <32 weeks gestation
Recruitment start date01/09/1995
Recruitment end date01/06/2019

Locations

Countries of recruitment

  • England
  • United Kingdom

Study participating centre

Wythenshawe Hospital
Manchester
M23 9LT
United Kingdom

Sponsor information

Wythenshawe Hospital (UK)
Hospital/treatment centre

c/o Andrew Maines
Research and Development Directorate
ERC Building
Wythenshawe Hospital
Southmoor Road
Manchester
M23 9LT
England
United Kingdom

Phone +44 (0)161 291 5775
Email andrew.maines@manchester.ac.uk
ROR logo "ROR" https://ror.org/05vpsdj37

Funders

Funder type

Charity

Asthma UK (UK)
Private sector organisation / Other non-profit organizations
Alternative name(s)
Asthma UK, Asthma + Lung UK
Location
United Kingdom
Moulton Charitable Trust (UK)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan

Study outputs

Output type Details Date created Date added Peer reviewed? Patient-facing?
Results article results 15/06/2008 Yes No
Results article results 01/06/2010 Yes No
Results article results 01/12/2015 Yes No
Results article results 15/10/2018 Yes No

Editorial Notes

11/02/2019: Publication reference added.
05/05/2016: Publication reference added.